Literature DB >> 27377621

Resident Macrophages in Muscle Contribute to Development of Hyperalgesia in a Mouse Model of Noninflammatory Muscle Pain.

Wei-Yi Gong1, Ramy E Abdelhamid2, Carolina S Carvalho2, Kathleen A Sluka3.   

Abstract

UNLABELLED: Macrophages play a role in innate immunity within the body, are located in muscle tissue, and can release inflammatory cytokines that sensitize local nociceptors. In this study we investigate the role of resident macrophages in the noninflammatory muscle pain model induced by 2 pH 4.0 preservative-free sterile saline (pH 4.0) injections 5 days apart in the gastrocnemius muscle. We showed that injecting 2 pH 4.0 injections into the gastrocnemius muscle increased the number of local muscle macrophages, and depleting muscle macrophages with clodronate liposomes before acid injections attenuated the hyperalgesia produced by this model. To further examine the contribution of local macrophages to this hyperalgesia, we injected mice intramuscularly with C34, a toll-like receptor 4 (TLR4) antagonist. When given before the first pH 4.0 injection, C34 attenuated the muscle and tactile hyperalgesia produced by the model. However, when given before the second injection C34 had no effect on the development of hyperalgesia. Then to test whether activation of local macrophages sensitizes nociceptors to normally non-nociceptive stimuli we replaced either the first or second acid injection with the immune cell activator lipopolysaccharide, or the inflammatory cytokine interleukin (IL)-6. Injecting LPS or IL-6 instead of the either the first or second pH 4.0 injection resulted in a dose-dependent increase in paw withdrawal responses and decrease in muscle withdrawal thresholds. The highest doses of LPS and IL-6 resulted in development of hyperalgesia bilaterally. The present study showed that resident macrophages in muscle are key to development of chronic muscle pain. PERSPECTIVE: This article presents evidence for the role of macrophages in the development of chronic muscle pain using a mouse model. These data suggest that macrophages could be a potential therapeutic target to prevent transition of acute to chronic muscle pain particularly in tissue acidosis conditions.
Copyright © 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Macrophages; cytokine; hyperalgesia; pain; proton

Mesh:

Substances:

Year:  2016        PMID: 27377621      PMCID: PMC5045810          DOI: 10.1016/j.jpain.2016.06.010

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  67 in total

1.  The expression of Toll-like receptor 4, 7 and co-receptors in neurochemical sub-populations of rat trigeminal ganglion sensory neurons.

Authors:  M P Helley; W Abate; S K Jackson; J H Bennett; S W N Thompson
Journal:  Neuroscience       Date:  2015-10-03       Impact factor: 3.590

2.  Rapid response of identified resident endoneurial macrophages to nerve injury.

Authors:  M Mueller; K Wacker; E B Ringelstein; W F Hickey; Y Imai; R Kiefer
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Monocytes/Macrophages control resolution of transient inflammatory pain.

Authors:  Hanneke L D M Willemen; Niels Eijkelkamp; Anibal Garza Carbajal; Huijing Wang; Matthias Mack; Jitske Zijlstra; Cobi J Heijnen; Annemieke Kavelaars
Journal:  J Pain       Date:  2014-05       Impact factor: 5.820

4.  Further evidence for a crucial role of resident endoneurial macrophages in peripheral nerve disorders: lessons from acrylamide-induced neuropathy.

Authors:  Marcus Müller; Karin Wacker; Daniel Getts; Erich Bernd Ringelstein; Reinhard Kiefer
Journal:  Glia       Date:  2008-07       Impact factor: 7.452

5.  Role of interleukin-6 in chronic muscle hyperalgesic priming.

Authors:  O A Dina; P G Green; J D Levine
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

6.  IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain.

Authors:  Morgana D da Silva; Franciane Bobinski; Karina L Sato; Sandra J Kolker; Kathleen A Sluka; Adair R S Santos
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

7.  Nociceptors are interleukin-1beta sensors.

Authors:  Alexander M Binshtok; Haibin Wang; Katharina Zimmermann; Fumimasa Amaya; Daniel Vardeh; Lin Shi; Gary J Brenner; Ru-Rong Ji; Bruce P Bean; Clifford J Woolf; Tarek A Samad
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

8.  Acid-sensing ion channels (ASICs) in mouse skeletal muscle afferents are heteromers composed of ASIC1a, ASIC2, and ASIC3 subunits.

Authors:  Mamta Gautam; Christopher J Benson
Journal:  FASEB J       Date:  2012-10-29       Impact factor: 5.191

9.  Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner.

Authors:  Dean Dessem; Ranjinidevi Ambalavanar; Melena Evancho; Aicha Moutanni; Chandrasekhar Yallampalli; Guang Bai
Journal:  Pain       Date:  2010-03-05       Impact factor: 7.926

10.  The effect of toll-like receptor 4 on macrophage cytokines during endotoxin induced uveitis.

Authors:  Shuo Yang; Hong Lu; Jing Wang; Xin Qi; Xuhui Liu; Xiaolong Zhang
Journal:  Int J Mol Sci       Date:  2012-06-18       Impact factor: 6.208

View more
  18 in total

1.  Establishment of a mouse model for injury-induced scar formation and the accompanying chronic pain: Comprehensive microarray analysis of molecular expressions in fibrosis and hyperalgesia.

Authors:  Yuqiang Li; Hiroki Iida; Koji Kimata; Lisheng Zhuo; Akinobu Ota; Shinya Kimura; Xiaojian Yin; Masataka Deie; Takahiro Ushida
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

2.  Chronic non-inflammatory muscle pain: central and peripheral mediators.

Authors:  Joseph Lesnak; Kathleen A Sluka
Journal:  Curr Opin Physiol       Date:  2019-06-18

3.  P2X4 Receptors on Muscle Macrophages Are Required for Development of Hyperalgesia in an Animal Model of Activity-Induced Muscle Pain.

Authors:  Maria Claudia Oliveira-Fusaro; Nicholas S Gregory; Sandra J Kolker; Lynn Rasmussen; Lee-Ann H Allen; Kathleen A Sluka
Journal:  Mol Neurobiol       Date:  2020-01-02       Impact factor: 5.590

Review 4.  Exercise-induced pain and analgesia? Underlying mechanisms and clinical translation.

Authors:  Kathleen A Sluka; Laura Frey-Law; Marie Hoeger Bement
Journal:  Pain       Date:  2018-09       Impact factor: 7.926

5.  Interleukin-4 mediates the analgesia produced by low-intensity exercise in mice with neuropathic pain.

Authors:  Franciane Bobinski; Juliana Maia Teixeira; Kathleen Anne Sluka; Adair Roberto Soares Santos
Journal:  Pain       Date:  2018-03       Impact factor: 7.926

Review 6.  Neural Pathways of Craniofacial Muscle Pain: Implications for Novel Treatments.

Authors:  M K Chung; S Wang; J Yang; I Alshanqiti; F Wei; J Y Ro
Journal:  J Dent Res       Date:  2020-05-06       Impact factor: 6.116

Review 7.  The contemporary model of vertebral column joint dysfunction and impact of high-velocity, low-amplitude controlled vertebral thrusts on neuromuscular function.

Authors:  Heidi Haavik; Nitika Kumari; Kelly Holt; Imran Khan Niazi; Imran Amjad; Amit N Pujari; Kemal Sitki Türker; Bernadette Murphy
Journal:  Eur J Appl Physiol       Date:  2021-06-23       Impact factor: 3.078

Review 8.  Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain.

Authors:  Hari Prasad Joshi; Hyun-Jung Jo; Yong-Ho Kim; Seong-Bae An; Chul-Kyu Park; Inbo Han
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 9.  Sex differences in neuroimmune and glial mechanisms of pain.

Authors:  Ann M Gregus; Ian S Levine; Kelly A Eddinger; Tony L Yaksh; Matthew W Buczynski
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

10.  Interleukin 1β inhibition contributes to the antinociceptive effects of voluntary exercise on ischemia/reperfusion-induced hypersensitivity.

Authors:  Jessica L Ross; Luis F Queme; Jordan E Lamb; Kathryn J Green; Zachary K Ford; Michael P Jankowski
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.